Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences Fund (JFNAX)

61.59
+0.82
+(1.35%)
At close: 8:01:22 PM EDT

Performance Overview

Morningstar Return Rating --
YTD Return -7.02%
5y Average Return 6.15%
Number of Years Up 13
Number of Years Down 2
Best 1Y Total Return (May 15, 2025) 55.59%
Worst 1Y Total Return (May 15, 2025) --
Best 3Y Total Return 55.59%
Worst 3Y Total Return 2.53%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
JFNAX
Category
YTD
0.63%
7.95%
1-Month
-0.31%
4.81%
3-Month
-4.99%
7.18%
1-Year
0.58%
30.16%
3-Year
7.07%
16.10%
5-Year
8.32%
15.71%
10-Year
7.26%
15.27%
Last Bull Market
8.07%
23.06%
Last Bear Market
-8.31%
-13.88%

Annual Total Return (%) History

Year
JFNAX
Category
2025
--
--
2024
3.40%
--
2023
7.30%
--
2022
-2.86%
--
2021
6.64%
--
2020
25.32%
27.63%
2019
28.98%
26.23%
2018
4.18%
-0.40%

2017
22.35%
24.31%
2016
-12.48%
-10.60%
2015
8.13%
8.05%
2014
34.68%
27.25%
2013
55.59%
48.17%
2012
24.51%
21.55%
2011
7.08%
7.66%
2010
8.11%
8.38%
2009
--
22.48%

Past Quarterly Returns

YearQ1Q2Q3Q4
2025 0.95% -- -- --
2024 8.52% 1.88% 5.33% -11.21%
2023 -1.32% 4.62% -4.15% 8.44%
2022 -5.27% -8.31% -1.92% 14.02%
2021 -2.70% 7.05% -0.89% 3.30%
2020 -13.68% 20.98% 5.25% 14.02%
2019 13.80% 2.14% -6.60% 18.81%
2018 3.72% 5.15% 10.05% -13.21%
2017 11.82% 7.15% 4.20% -2.01%
2016 -13.52% 5.68% 4.35% -8.23%

2015 13.15% 4.38% -12.63% 4.79%
2014 7.14% 6.12% 7.23% 10.48%
2013 14.64% 5.86% 16.46% 10.08%
2012 15.11% -0.25% 8.60% -0.16%
2011 6.95% 6.09% -13.58% 9.20%
2010 4.04% -12.04% 12.32% 5.18%
2009 5.84% -- -- --

Rank in Category (By Total Return)

YTD 33
1-Month 43
3-Month 30
1-Year 45
3-Year 7
5-Year 10

Load Adjusted Returns

1-Year -5.20%
3-Year 4.98%
5-Year 7.05%
10-Year 6.63%

Performance & Risk

YTD Return -7.02%
5y Average Return 6.15%
Rank in Category (ytd) 33
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.68
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Janus Henderson
Net Assets 4.66B
YTD Return 0.63%
Yield 0.13%
Morningstar Rating
Inception Date Jul 06, 2009

Fund Summary

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Related Tickers